Advances in Targeted Protein Degradation | Bio-Techne 14 July 2021
This author has not written his bio yet.
But we are proud to say that Dsimmons contributed 14 entries already.
Entries by Dsimmons
Protein degradation: Looking back and moving forward – Endpoints Webinars (endpts.com) 13 July 2021
Amphista Therapeutics Expands Research Team by Appointing Martin O’Rourke as Head of Drug Discovery and James Osborne as Director of Chemistry Glasgow, Scotland, 28 June 2021 – Amphista Therapeutics, a Targeted Protein Degradation (TPD) biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes to remove disease-causing proteins selectively and efficiently, today […]
Undruggable Leaders Forum Europe 13 April 2021 – 14 April 2021